Try our Advanced Search for more refined results

Novartis Sues Ranbaxy Over Top-Selling Diovan

By Ben James (August 13, 2007, 12:00 AM EDT) -- Novartis International AG has sued Ranbaxy Laboratories Limited, looking to stave off generic competition in the multibillion dollar market for the hypertension treatment Diovan, which Novartis touts as the world's leading branded high blood pressure medication....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!